DOCSLIB.ORG

The Role of Peroxisome in Osteoblast Differentiation and Functions

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Role of Peroxisome in Osteoblast Differentiation and Functions The role of peroxisomes in osteoblast differentiation and functions Inaugural Dissertation submitted to the Faculty of Medicine in partial fulfillment of the requirements for the PhD-Degree of the Faculties of Veterinary Medicine and Medicine of the Justus Liebig University Giessen By Fan, Wei Of Zhengzhou China Giessen 2014 1 From the Institute for Anatomy and Cell Biology, Division of Medical Cell Biology Director/Chairperson: Prof. Dr. Eveline Baumgart-Vogt of the Faculty of Medicine of Justus Liebig University Giessen First Supervisor and Committee Member: Prof. Dr. Eveline Baumgart-Vogt Second Supervisor and Committee Member: Prof. Dr. Martin Diener Examination chair and Committee Member: Prof. Dr. Klaus-Dieter Schlüter Date of Doctoral Defense: 22nd September 2015 2 Declaration “I declare that I have completed this dissertation single-handedly without the unauthorized help of a second party and only with the assistance acknowledged therein. I have appropriately acknowledged and referenced all text passages that are derived literally from or are based on the content of published or unpublished work of others, and all information that relates to verbal communications. I have abided by the principles of good scientific conduct laid down in the charter of the Justus Liebig University of Giessen in carrying out the investigations described in the dissertation.” Giessen, November 25th 2014 Fan, Wei 3 Table of Contents 1. Literature Review and Introduction .............................................................................5 1.1. The peroxisome structure, functions and biogenesis ...........................................5 1.1.1. Basic morphology and metabolic function of peroxisomes ......................................... 5 1.1.2. Peroxisome biogenesis ..................................................................................................... 8 1.1.3. Enzyme composition and metabolic functions in peroxisomes ................................ 19 1.2. Peroxisome biogenesis disorders .......................................................................... 28 1.2.1. The peroxisome biogenesis disorders and human diseases .................................... 28 1.2.2. Animal models for peroxisome biogenesis disorders ................................................. 29 1.3. Cells of the bone and their role in bone remodeling and the pathogenesis of osteoporosis .................................................................................................................... 32 1.3.1 The major types of bone cells and functions ................................................................ 32 1.3.2. Osteobiogenesis, osteoblast differentiation and functional alterations ................... 34 1.4. Bone phenotype and peroxisomal phenotype in the Sirt1 KO mouse model ... 38 2. Aims of the study ......................................................................................................... 40 3. Materials and Methods ................................................................................................ 42 3.1. General Materials used in the laboratory .............................................................. 42 3.1.1. Chemicals for the general application of molecular and morphological experiments ....................................................................................................................................................... 42 3.1.2. Laboratory general instruments ..................................................................................... 44 3.1.3. The General materials for cell culture .......................................................................... 46 3.2. Experimental animals ............................................................................................... 47 3.2.1. Pex11β KO and Pex13 KO animals in Germany ........................................................ 47 3.2.2 Sirt1 whole body KO mice experiment in the USA ...................................................... 47 3.3. Methods ..................................................................................................................... 48 3.3.1. Primary osteoblasts and MC3T3-E1 pre-osteoblast-like fibroblast cell line ........... 48 3.3.2. Transfection of MC3T3-E1 cells and primary osteoblast ........................................... 50 3.4. Molecular biological experiments........................................................................... 52 3.4.1. RNA isolation from primary osteoblast and MC3T3-E1 cell culture and the reverse transcription to generate cDNA ................................................................................................ 52 1 3.4.2. Semi-quantitative polymerase chain reaction and agarose gel electrophoresis. .. 52 3.4.3. Quantitative real time-polymerase chain reaction ...................................................... 55 3.4.4. Osteoblast protein abundance analysis via Western blots ....................................... 56 3.5 Morphological experiments ...................................................................................... 61 3.5.1. Indirect immunofluorescence stainings of primary osteoblasts ................................ 61 3.5.2. Indirect immunofluorescence staining on Paraformaldehyde-fixed paraffin- embedded mouse tissue ........................................................................................................... 62 3.5.3. Apoptosis detection by terminal deoxynucleotidyl transferase dUTP nick end labeling ......................................................................................................................................... 63 3.5.4. Whole skeleton bone volume and bone density estimation using flat-panel volumetric computed tomography (fpvCT) of P0.5 mouse pups. ........................................ 64 3.6. Functional assay of protein DNA binding, biophysical methodology ............... 65 3.6.1. Dual-Luciferase reporter gene assay to monitor transcriptional activities of markers of bone differentiation RUNX2 and FoxOs, PPARs. .............................................. 65 3.6.2. Biophysical Methodology to determine cell cycle of primary osteoblasts ............... 67 3.6.3. Flow cytometric analysis of ROS in Sirt1 gene shRNA knockdown MC3T3-E1 cells ....................................................................................................................................................... 69 3.7 Numerical data presentation and statistical analysis ........................................... 70 4. Results: ......................................................................................................................... 71 4.1. Part I: The Pex11β gene KO causes peroxisomal dysfunction, resulting in osteoblast differentiation delay and severe cell signaling alterations. .................... 71 4.1.1. Pex11β KO in primary osteoblasts and Pex11β gene knockdown via Pex11β shRNA in the MC3T3-E1 cell line ............................................................................................. 71 4.1.2. The Pex11β gene KO results in dramatically decreasing the expression level of the peroxisomal functional enzymes........................................................................................ 73 4.1.3. Osteoblast differentiation and maturation were severely altered in the primary osteoblast cells culture with Pex11β KO ................................................................................. 76 4.1.4. The DNA binding functions of key nuclear receptors regulating the osteoblast differentiation and function were significantly altered in Pex11β KO osteoblasts. ........... 78 4.1.5. Significantly higher amount of apoptosis of primary Pex11β KO compared to WT osteoblasts. .................................................................................................................................. 82 4.1.6. Strong disruption of the cell cycle and proliferation rate in Pex11β KO osteoblast 84 2 4.2. Part II: The Pex13 KO caused peroxisomal biogenesis defect result in the interference with the antioxidative response, osteoblast differentiation and maturation ......................................................................................................................... 86 4.2.1. Pex13 KO mice (P0.5) exhibit a delay in the ossification process ........................... 86 4.2.2. Peroxisomal biogenesis genes and the osteoblast differentiation process were disturbed. ..................................................................................................................................... 91 4.2.3. The oxidative response is stimulated by oxidative stress in the bone cells of Pex13 KO mice due to peroxisomal dysfunction ................................................................................ 92 4.2.4. The DNA binding activity of the Runx2 nuclear receptor which regulates osteoblast differentiation and function was significantly attenuated in primary osteoblast of Pex13 KO mice........................................................................................................................................ 95 4.3. Part III: SIRT1 deficiency impairs peroxisomal functions and promotes pre- mature differentiation of pre-osteoblasts and abnormal bone development in mice ............................................................................................................................................ 97 4.3.1. SIRT1 protein level is altered in primary osteoblast with peroxisomal deficiency.
Load more

Recommended publications
  • ACOX3 Antibody
    Product Datasheet ACOX3 antibody Catalog No: #22136 Orders: [email protected] Description Support: [email protected] Product Name ACOX3 antibody Host Species Rabbit Clonality Polyclonal Purification Purified by antigen-affinity chromatography. Applications WB IHC Species Reactivity Hu Immunogen Type Recombinant protein Immunogen Description Recombinant protein fragment contain a sequence corresponding to a region within amino acids 408 and 613 of ACOX3 Target Name ACOX3 Accession No. Swiss-Prot:O15254Gene ID:8310 Concentration 1mg/ml Formulation Supplied in 0.1M Tris-buffered saline with 20% Glycerol (pH7.0). 0.01% Thimerosal was added as a preservative. Storage Store at -20°C for long term preservation (recommended). Store at 4°C for short term use. Application Details Predicted MW: 70kd Western blotting: 1:500-1:3000 Immunohistochemistry: 1:100-1:500 Images Sample (30 ug of whole cell lysate) A: A549 7.5% SDS PAGE Primary antibody diluted at 1: 1000 Address: 8400 Baltimore Ave., Suite 302, College Park, MD 20740, USA http://www.sabbiotech.com 1 Immunohistochemical analysis of paraffin-embedded H441 xenograft, using ACOX3 antibody at 1: 500 dilution. Background Acyl-Coenzyme A oxidase 3 also know as pristanoyl -CoA oxidase (ACOX3)is involved in the desaturation of 2-methyl branched fatty acids in peroxisomes. Unlike the rat homolog, the human gene is expressed in very low amounts in liver such that its mRNA was undetectable by routine Northern-blot analysis or its product by immunoblotting or by enzyme activity measurements. However the human cDNA encoding a 700 amino acid protein with a peroxisomal targeting C-terminal tripeptide S-K-L was isolated and is thought to be expressed under special conditions such as specific developmental stages or in a tissue specific manner in tissues that have not yet been examined.
    [Show full text]
  • ACOX3 Human Shrna Plasmid Kit (Locus ID 8310) Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for TL314988 ACOX3 Human shRNA Plasmid Kit (Locus ID 8310) Product data: Product Type: shRNA Plasmids Product Name: ACOX3 Human shRNA Plasmid Kit (Locus ID 8310) Locus ID: 8310 Vector: pGFP-C-shLenti (TR30023) Format: Lentiviral plasmids Components: ACOX3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 8310). 5µg purified plasmid DNA per construct Non-effective 29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. RefSeq: NM_001101667, NM_003501, NM_003501.1, NM_003501.2, NM_001101667.1, BC017053, NM_003501.3, NM_001101667.2 Summary: Acyl-Coenzyme A oxidase 3 also know as pristanoyl -CoA oxidase (ACOX3)is involved in the desaturation of 2-methyl branched fatty acids in peroxisomes. Unlike the rat homolog, the human gene is expressed in very low amounts in liver such that its mRNA was undetectable by routine Northern-blot analysis or its product by immunoblotting or by enzyme activity measurements. However the human cDNA encoding a 700 amino acid protein with a peroxisomal targeting C-terminal tripeptide S-K-L was isolated and is thought to be expressed under special conditions such as specific developmental stages or in a tissue specific manner in tissues that have not yet been examined. [provided by RefSeq, Jul 2008] shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact [email protected].
    [Show full text]
  • ACOX3 (H-1): Sc-390624
    SAN TA C RUZ BI OTEC HNOL OG Y, INC . ACOX3 (H-1): sc-390624 BACKGROUND APPLICATIONS ACOX3 (acyl-Coenzyme A oxidase 3), also known as BRCOX or PRCOX, is a ACOX3 (H-1) is recommended for detection of ACOX3 of mouse, rat and 700 amino acid protein that localizes to peroxisomes and belongs to the acyl- human origin by Western Blotting (starting dilution 1:100, dilution range CoA oxidase family. Using FAD as a cofactor, ACOX3 catalyzes the desatura - 1:100-1:1000), immunoprecipitation [1-2 µg per 100-500 µg of total protein tion of 2-methyl branched fatty acids in peroxisomes, thereby playing an impor - (1 ml of cell lysate)], immunofluorescence (starting dilution 1:50, dilution tant role in peroxisomal fatty acid β-oxidation. Human ACOX3 shares 75% range 1:50-1:500) and solid phase ELISA (starting dilution 1:30, dilution sequence identity with its rat counterpart, suggesting a conserved role range 1:30-1:3000). between species. Multiple isoforms of ACOX3 exist due to alternative splic - Suitable for use as control antibody for ACOX3 siRNA (h): sc-89236, ACOX3 ing events. The gene encoding ACOX3 maps to human chromosome 4, which siRNA (m): sc-140819, ACOX3 shRNA Plasmid (h): sc-89236-SH, ACOX3 encodes nearly 6% of the human genome and has the largest gene deserts shRNA Plasmid (m): sc-140819-SH, ACOX3 shRNA (h) Lentiviral Particles: (regions of the genome with no protein encoding genes) of all of the human sc-89236-V and ACOX3 shRNA (m) Lentiviral Particles: sc-140819-V. chromosomes. Defects in some of the genes located on chromosome 4 are associated with Huntington’s disease, Ellis-van Creveld syndrome, methyl - Molecular Weight of ACOX3: 78 kDa.
    [Show full text]
  • PEX5 Regulates Autophagy Via the Mtorc1-TFEB Axis During Starvation
    Eun et al. Experimental & Molecular Medicine (2018) 50:4 DOI 10.1038/s12276-017-0007-8 Experimental & Molecular Medicine ARTICLE Open Access PEX5 regulates autophagy via the mTORC1-TFEB axis during starvation So Young Eun1,JoonNoLee2,In-KooNam2, Zhi-qiang Liu1,Hong-SeobSo 1, Seong-Kyu Choe1 and RaeKil Park2 Abstract Defects in the PEX5 gene impair the import of peroxisomal matrix proteins, leading to nonfunctional peroxisomes and other associated pathological defects such as Zellweger syndrome. Although PEX5 regulates autophagy process in a stress condition, the mechanisms controlling autophagy by PEX5 under nutrient deprivation are largely unknown. Herein, we show a novel function of PEX5 in the regulation of autophagy via Transcription Factor EB (TFEB). Under serum-starved conditions, when PEX5 is depleted, the mammalian target of rapamycin (mTORC1) inhibitor TSC2 is downregulated, which results in increased phosphorylation of the mTORC1 substrates, including 70S6K, S6K, and 4E- BP-1. mTORC1 activation further suppresses the nuclear localization of TFEB, as indicated by decreased mRNA levels of TFEB, LIPA, and LAMP1. Interestingly, peroxisomal mRNA and protein levels are also reduced by TFEB inactivation, indicating that TFEB might control peroxisome biogenesis at a transcriptional level. Conversely, pharmacological inhibition of mTOR resulting from PEX5 depletion during nutrient starvation activates TFEB by promoting nuclear localization of the protein. In addition, mTORC1 inhibition recovers the damaged-peroxisome biogenesis. These data suggest that PEX5 may be a critical regulator of lysosomal gene expression and autophagy through the mTOR-TFEB- autophagy axis under nutrient deprivation. 1234567890():,; 1234567890():,; Introduction Mitochondrial antiviral-signaling protein (MAVS) func- Peroxisome is an essential cellular organelle for per- tions as an antiviral signaling platform to induce the forming various metabolic activities, including oxidation interferon-independent signaling pathways4.
    [Show full text]
  • Adipose Tissue NAPE-PLD Controls Fat Mass Development by Altering the Browning Process and Gut Microbiota
    ARTICLE Received 11 Jul 2014 | Accepted 4 Feb 2015 | Published 11 Mar 2015 DOI: 10.1038/ncomms7495 OPEN Adipose tissue NAPE-PLD controls fat mass development by altering the browning process and gut microbiota Lucie Geurts1, Amandine Everard1,*, Matthias Van Hul1,*, Ahmed Essaghir2, Thibaut Duparc1, Se´bastien Matamoros1, Hubert Plovier1, Julien Castel3, Raphael G.P. Denis3, Marie Bergiers1, Ce´line Druart1, Mireille Alhouayek4, Nathalie M. Delzenne1, Giulio G. Muccioli4, Jean-Baptiste Demoulin2, Serge Luquet3 & Patrice D. Cani1 Obesity is a pandemic disease associated with many metabolic alterations and involves several organs and systems. The endocannabinoid system (ECS) appears to be a key regulator of energy homeostasis and metabolism. Here we show that specific deletion of the ECS synthesizing enzyme, NAPE-PLD, in adipocytes induces obesity, glucose intolerance, adipose tissue inflammation and altered lipid metabolism. We report that Napepld-deleted mice present an altered browning programme and are less responsive to cold-induced browning, highlighting the essential role of NAPE-PLD in regulating energy homeostasis and metabolism in the physiological state. Our results indicate that these alterations are mediated by a shift in gut microbiota composition that can partially transfer the phenotype to germ-free mice. Together, our findings uncover a role of adipose tissue NAPE-PLD on whole-body metabolism and provide support for targeting NAPE-PLD-derived bioactive lipids to treat obesity and related metabolic disorders. 1 Metabolism and Nutrition Research Group, WELBIO-Walloon Excellence in Life Sciences and BIOtechnology, Louvain Drug Research Institute, Universite´ catholique de Louvain, Avenue E. Mounier, 73 B1.73.11, 1200 Brussels, Belgium. 2 de Duve Institute, Universite´ catholique de Louvain, Avenue Hippocrate, 74 B1.74.05, 1200 Brussels, Belgium.
    [Show full text]
  • The Association of Peroxisomes with the Developing Cell Plate in Dividing Onion Root Cells Depends on Actin Microfilaments and Myosin
    Planta (2003) 218: 204–216 DOI 10.1007/s00425-003-1096-2 ORIGINAL ARTICLE David A. Collings Æ John D. I. Harper Æ Kevin C. Vaughn The association of peroxisomes with the developing cell plate in dividing onion root cells depends on actin microfilaments and myosin Received: 5 April 2003 / Accepted: 23 June 2003 / Published online: 21 August 2003 Ó Springer-Verlag 2003 Abstract We have investigated changes in the distribu- cling of excess membranes from secretory vesicles via the tion of peroxisomes through the cell cycle in onion b-oxidation pathway. Differences in aggregation, a (Allium cepa L.) root meristem cells with immunofluo- phenomenon which occurs in onion, some other mono- rescence and electron microscopy, and in leek (Allium cots and to a lesser extent in tobacco BY-2 suspension porrum L.) epidermal cells with immunofluorescence and cells, but which is not obvious in the roots of Arabidopsis peroxisomal-targeted green fluorescent protein. During thaliana (L.) Heynh., may reflect differences within the interphase and mitosis, peroxisomes distribute randomly primary cell walls of these plants. throughout the cytoplasm, but beginning late in ana- phase, they accumulate at the division plane. Initially, Keywords Actin microfilaments Æ Allium Æ peroxisomes occur within the microtubule phragmoplast Microtubule Æ Cell plate Æ Peroxisome Æ Phragmoplast in two zones on either side of the developing cell plate. However, as the phragmoplast expands outwards to Abbreviations BDM: 2,3-butanedione monoxime Æ DAPI: form an annulus, peroxisomes redistribute into a ring 4¢,6-diamidino-2-phenylindole Æ ER: endoplasmic reti- immediately inside the location of the microtubules.
    [Show full text]
  • Hif-2A Promotes Degradation of Mammalian Peroxisomes by Selective Autophagy
    Cell Metabolism Article Hif-2a Promotes Degradation of Mammalian Peroxisomes by Selective Autophagy Katharina M. Walter,1,2,10 Miriam J. Scho¨ nenberger,1,2,10 Martin Tro¨ tzmu¨ ller,3 Michael Horn,1 Hans-Peter Elsa¨ sser,4 Ann B. Moser,5 Miriam S. Lucas,6 Tobias Schwarz,6 Philipp A. Gerber,7 Phyllis L. Faust,8 Holger Moch,9 Harald C. Ko¨ feler,3 Wilhelm Krek,1,2,* and Werner J. Kovacs1,2,* 1Institute of Molecular Health Sciences 2Competence Center for Systems Physiology and Metabolic Diseases ETH Zurich, CH-8093 Zurich, Switzerland 3Core Facility for Mass Spectrometry, Center for Medical Research, Medical University of Graz, A-8010 Graz, Austria 4Department of Cytobiology, Philipps-University Marburg, D-35037 Marburg, Germany 5Kennedy Krieger Institute, Baltimore, MD 21205, USA 6ScopeM – Scientific Center for Optical and Electron Microscopy, ETH Zurich, CH-8093 Zurich, Switzerland 7Division of Endocrinology and Diabetes, University Hospital Zurich, CH-8091 Zurich, Switzerland 8Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA 9Institute of Surgical Pathology, University Hospital Zurich, CH-8091 Zurich, Switzerland 10Co-first Authors *Correspondence: [email protected] (W.K.), [email protected] (W.J.K.) http://dx.doi.org/10.1016/j.cmet.2014.09.017 SUMMARY expressed HIF-1b subunit and O2-regulated a subunits (HIF-1a and HIF-2a)(Keith et al., 2012). Under normoxia, HIF-a subunits Peroxisomes play a central role in lipid metabolism, are hydroxylated and targeted for proteasomal degradation by and their function depends on molecular oxygen.
    [Show full text]
  • Novel and Highly Recurrent Chromosomal Alterations in Se´Zary Syndrome
    Research Article Novel and Highly Recurrent Chromosomal Alterations in Se´zary Syndrome Maarten H. Vermeer,1 Remco van Doorn,1 Remco Dijkman,1 Xin Mao,3 Sean Whittaker,3 Pieter C. van Voorst Vader,4 Marie-Jeanne P. Gerritsen,5 Marie-Louise Geerts,6 Sylke Gellrich,7 Ola So¨derberg,8 Karl-Johan Leuchowius,8 Ulf Landegren,8 Jacoba J. Out-Luiting,1 Jeroen Knijnenburg,2 Marije IJszenga,2 Karoly Szuhai,2 Rein Willemze,1 and Cornelis P. Tensen1 Departments of 1Dermatology and 2Molecular Cell Biology, Leiden University Medical Center, Leiden, the Netherlands; 3Department of Dermatology, St Thomas’ Hospital, King’s College, London, United Kingdom; 4Department of Dermatology, University Medical Center Groningen, Groningen, the Netherlands; 5Department of Dermatology, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands; 6Department of Dermatology, Gent University Hospital, Gent, Belgium; 7Department of Dermatology, Charite, Berlin, Germany; and 8Department of Genetics and Pathology, Rudbeck Laboratory, University of Uppsala, Uppsala, Sweden Abstract Introduction This study was designed to identify highly recurrent genetic Se´zary syndrome (Sz) is an aggressive type of cutaneous T-cell alterations typical of Se´zary syndrome (Sz), an aggressive lymphoma/leukemia of skin-homing, CD4+ memory T cells and is cutaneous T-cell lymphoma/leukemia, possibly revealing characterized by erythroderma, generalized lymphadenopathy, and pathogenetic mechanisms and novel therapeutic targets. the presence of neoplastic T cells (Se´zary cells) in the skin, lymph High-resolution array-based comparative genomic hybridiza- nodes, and peripheral blood (1). Sz has a poor prognosis, with a tion was done on malignant T cells from 20 patients. disease-specific 5-year survival of f24% (1).
    [Show full text]
  • Downloaded As a Text File, Is Completely Dynamic
    BMC Bioinformatics BioMed Central Database Open Access ORENZA: a web resource for studying ORphan ENZyme activities Olivier Lespinet and Bernard Labedan* Address: Institut de Génétique et Microbiologie, CNRS UMR 8621, Université Paris-Sud, Bâtiment 400, 91405 Orsay Cedex, France Email: Olivier Lespinet - [email protected]; Bernard Labedan* - [email protected] * Corresponding author Published: 06 October 2006 Received: 25 July 2006 Accepted: 06 October 2006 BMC Bioinformatics 2006, 7:436 doi:10.1186/1471-2105-7-436 This article is available from: http://www.biomedcentral.com/1471-2105/7/436 © 2006 Lespinet and Labedan; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Background: Despite the current availability of several hundreds of thousands of amino acid sequences, more than 36% of the enzyme activities (EC numbers) defined by the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB) are not associated with any amino acid sequence in major public databases. This wide gap separating knowledge of biochemical function and sequence information is found for nearly all classes of enzymes. Thus, there is an urgent need to explore these sequence-less EC numbers, in order to progressively close this gap. Description: We designed ORENZA, a PostgreSQL database of ORphan ENZyme Activities, to collate information about the EC numbers defined by the NC-IUBMB with specific emphasis on orphan enzyme activities.
    [Show full text]
  • Autophagy Stimulus-Dependent Role of the Small Gtpase Ras2 in Peroxisome Degradation
    biomolecules Communication Autophagy Stimulus-Dependent Role of the Small GTPase Ras2 in Peroxisome Degradation Fahd Boutouja 1,2 and Harald W. Platta 1,* 1 Biochemie Intrazellulärer Transportprozesse, Ruhr-Universität Bochum, 44801 Bochum, Germany; [email protected] 2 Institute of Pathobiochemistry, Johannes Gutenberg-University Mainz, 55099 Mainz, Germany * Correspondence: [email protected]; Tel.: +49-234-322-4968 Received: 17 October 2020; Accepted: 12 November 2020; Published: 14 November 2020 Abstract: The changing accessibility of nutrient resources induces the reprogramming of cellular metabolism in order to adapt the cell to the altered growth conditions. The nutrient-depending signaling depends on the kinases mTOR (mechanistic target of rapamycin), which is mainly activated by nitrogen-resources, and PKA (protein kinase A), which is mainly activated by glucose, as well as both of their associated factors. These systems promote protein synthesis and cell proliferation, while they inhibit degradation of cellular content by unselective bulk autophagy. Much less is known about their role in selective autophagy pathways, which have a more regulated cellular function. Especially, we were interested to analyse the central Ras2-module of the PKA-pathway in the context of peroxisome degradation. Yeast Ras2 is homologous to the mammalian Ras proteins, whose mutant forms are responsible for 33% of human cancers. In the present study, we were able to demonstrate a context-dependent role of Ras2 activity depending on the type of mTOR-inhibition and glucose-sensing situation. When mTOR was inhibited directly via the macrolide rapamycin, peroxisome degradation was still partially suppressed by Ras2, while inactivation of Ras2 resulted in an enhanced degradation of peroxisomes, suggesting a role of Ras2 in the inhibition of peroxisome degradation in glucose-grown cells.
    [Show full text]
  • Regions of Homozygosity Identified by SNP Microarray Analysis Aid in The
    ORIGINAL RESEARCH ARTICLE ©American College of Medical Genetics and Genomics Regions of homozygosity identified bySN P microarray analysis aid in the diagnosis of autosomal recessive disease and incidentally detect parental blood relationships Kristen Lipscomb Sund, PhD, MS1, Sarah L. Zimmerman, PhD1, Cameron Thomas, MD2, Anna L. Mitchell, MD, PhD3, Carlos E. Prada, MD1, Lauren Grote, BS1, Liming Bao, MD, PhD1, Lisa J. Martin, PhD1 and Teresa A. Smolarek, PhD1 Purpose: The purpose of this study was to document the ability of was suspected in the parents of at least 11 patients with regions of single-nucleotide polymorphism microarray to identify copy-neutral homozygosity covering >21.3% of their autosome. In four patients regions of homozygosity, demonstrate clinical utility of regions of from two families, homozygosity mapping discovered a candidate homozygosity, and discuss ethical/legal implications when regions of gene that was sequenced to identify a clinically significant mutation. homozygosity are associated with a parental blood relationship. Conclusion: This study demonstrates clinical utility in the identifica- Methods: Study data were compiled from consecutive samples tion of regions of homozygosity, as these regions may aid in diagnosis sent to our clinical laboratory over a 3-year period. A cytogenetics of the patient. This study establishes the need for careful reporting, database identified patients with at least two regions of homozygosity thorough pretest counseling, and careful electronic documentation, >10 Mb on two separate chromosomes. A chart review was conduct- as microarray has the capability of detecting previously unknown/ ed on patients who met the criteria. unreported relationships. Results: Of 3,217 single-nucleotide polymorphism microarrays, Genet Med 2013:15(1):70–78 59 (1.8%) patients met inclusion criteria.
    [Show full text]
  • The Membrane Remodeling Protein Pex11p Activates the Gtpase Dnm1p During Peroxisomal Fission
    The membrane remodeling protein Pex11p activates the GTPase Dnm1p during peroxisomal fission Chris Williamsa, Lukasz Opalinskia,b,1, Christiane Landgrafc, Joseph Costellod, Michael Schraderd, Arjen M. Krikkena,b, Kèvin Knoopsa, Anita M. Krama,b, Rudolf Volkmerc,e, and Ida J. van der Kleia,b,2 aMolecular Cell Biology, Groningen Biomolecular Sciences and Biotechnology Institute, and bKluyver Centre for Genomics of Industrial Fermentation, University of Groningen, 9747 AG Groningen, The Netherlands; cInstitut für Medizinische Immunologie, Charité-Universitätsmedizin Berlin, 10115 Berlin, Germany; dCollege of Life and Environmental Sciences, Biosciences, University of Exeter, Exeter EX4 4QD, United Kingdom; and eLeibniz-Institut für Molekulare Pharmakologie, 13125 Berlin, Germany Edited by Jennifer Lippincott-Schwartz, National Institutes of Health, Bethesda, MD, and approved April 14, 2015 (received for review October 9, 2014) The initial phase of peroxisomal fission requires the peroxisomal Fis1p and (in S. cerevisiae) the accessory proteins Mdv1p and membrane protein Peroxin 11 (Pex11p), which remodels the mem- Caf4p (12). Interestingly these proteins are also responsible for brane, resulting in organelle elongation. Here, we identify an ad- mitochondrial fission in yeast (13). ditional function for Pex11p, demonstrating that Pex11p also plays Dnm1p (Drp1 in mammals) (11, 14) is a large GTPase that a crucial role in the final step of peroxisomal fission: dynamin-like achieves membrane fission by forming oligomeric, ring-like struc- protein (DLP)-mediated membrane scission. First, we demonstrate tures around constricted sites on organelle membranes (15). Powered that yeast Pex11p is necessary for the function of the GTPase by GTP hydrolysis, these ring-like structures then tighten further Dynamin-related 1 (Dnm1p) in vivo.
    [Show full text]